JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Dyck, C. H.
Right arrow Articles by Gelernter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Dyck, C. H.
Right arrow Articles by Gelernter, J.
Journal of Nuclear Medicine Vol. 46 No. 5 745-751
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene

Christopher H. van Dyck, MD1,2,3, Robert T. Malison, MD1, Leslie K. Jacobsen, MD1,3, John P. Seibyl, MD1,3,4, Julie K. Staley, PhD1,3, Marc Laruelle, MD1,3, Ronald M. Baldwin, PhD1,3, Robert B. Innis, MD, PhD1,3 and Joel Gelernter, MD1,3

1 Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
2 Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut
3 VA Connecticut Healthcare System, West Haven, Connecticut
4 Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut

A polymorphism involving a variable number of tandem repeats (VNTR) has been described in the 3' untranslated region of the gene (SLC6A3) coding for the dopamine transporter (DAT). This polymorphism has 2 common alleles, designated as 10-repeat (*10R) and 9-repeat (*9R), that have been linked with several human clinical phenotypes. Previous investigations of the effects of the SLC6A3 polymorphism on DAT availability in smaller samples of humans have yielded divergent results. Methods: We assessed genotype at the SLC6A3 promoter VNTR polymorphism in 96 healthy European Americans (age range, 18–88 y) who also underwent SPECT with 123I-2ß-carbomethoxy-3ß-(4-iodophenyl)tropane (ß-CIT) for measurement of striatal DAT protein availability. A ratio of specific to nondisplaceable brain uptake (i.e., V3'' = [striatal -occipital]/occipital), a measure proportional to the binding potential, was derived. For this analysis, 9–9 homozygotes and 9–10 heterozygotes were grouped as SLC6A3*9R carriers and contrasted with SLC6A3*10R homozygotes. Results: The SLC6A3*9R carriers had significantly higher striatal DAT availability (V3'') than did the SLC6A3*10R homozygotes, controlling for age (F1,93 = 6.25, P = 0.014, analysis of covariance). The *9R carriers (n = 41, 49.8 ± 19.5 y) had a mean increase in striatal DAT availability of 8.9% relative to the *10R homozygotes (n = 53, 49.9 ± 19.2 y). Striatal subregion analysis revealed that the effect of DAT genotype was significant for both the caudate and the putamen. Conclusion: These results support the interpretation of higher DAT levels in association with the *9R allele in European Americans and may relate to previously observed associations between DAT genotype and neuropsychiatric diseases.

Key Words: 123I-ß-CIT • SPECT • dopamine transporter • genotype • VNTR


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
Proc R Soc BHome page
S. Zhong, S. Israel, H. Xue, P. C. Sham, R. P. Ebstein, and S. H. Chew
A neurochemical approach to valuation sensitivity over gains and losses
Proc R Soc B, December 7, 2009; 276(1676): 4181 - 4188.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. P. Prata, A. Mechelli, M. M. Picchioni, C. H. Y. Fu, T. Toulopoulou, E. Bramon, M. Walshe, R. M. Murray, D. A. Collier, and P. McGuire
Altered Effect of Dopamine Transporter 3'UTR VNTR Genotype on Prefrontal and Striatal Function in Schizophrenia
Arch Gen Psychiatry, November 1, 2009; 66(11): 1162 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. N. Bamne, M. E. Talkowski, K. V. Chowdari, and V. L. Nimgaonkar
Functional Analysis of Upstream Common Polymorphisms of the Dopamine Transporter Gene
Schizophr Bull, March 9, 2009; (2009) sbp005v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bertolino, L. Fazio, A. Di Giorgio, G. Blasi, R. Romano, P. Taurisano, G. Caforio, L. Sinibaldi, G. Ursini, T. Popolizio, et al.
Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans
J. Neurosci., January 28, 2009; 29(4): 1224 - 1234.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-C. Dreher, P. Kohn, B. Kolachana, D. R. Weinberger, and K. F. Berman
Variation in dopamine genes influences responsivity of the human reward system
PNAS, January 13, 2009; 106(2): 617 - 622.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. M. van de Giessen, M. M.L. de Win, M. W.T. Tanck, W. van den Brink, F. Baas, and J. Booij
Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3
J. Nucl. Med., January 1, 2009; 50(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
G. Florez, P. Saiz, P. Garcia-Portilla, S. Alvarez, L. Nogueiras, B. Morales, V. Alvarez, E. Coto, and J. Bobes
Association Between the Stin2 VNTR Polymorphism of the Serotonin Transporter Gene and Treatment Outcome in Alcohol-Dependent Patients
Alcohol Alcohol., September 1, 2008; 43(5): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
R. Cools
Role of Dopamine in the Motivational and Cognitive Control of Behavior
Neuroscientist, August 1, 2008; 14(4): 381 - 395.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yacubian, T. Sommer, K. Schroeder, J. Glascher, R. Kalisch, B. Leuenberger, D. F. Braus, and C. Buchel
Gene gene interaction associated with neural reward sensitivity
PNAS, May 8, 2007; 104(19): 8125 - 8130.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. N.P. Kelada, H. Checkoway, S. L.R. Kardia, C. S. Carlson, P. Costa-Mallen, D. L. Eaton, J. Firestone, K. M. Powers, P. D. Swanson, G. M. Franklin, et al.
5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study
Hum. Mol. Genet., October 15, 2006; 15(20): 3055 - 3062.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al.
Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens.
Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bertolino, G. Blasi, V. Latorre, V. Rubino, A. Rampino, L. Sinibaldi, G. Caforio, V. Petruzzella, A. Pizzuti, T. Scarabino, et al.
Additive Effects of Genetic Variation in Dopamine Regulating Genes on Working Memory Cortical Activity in Human Brain
J. Neurosci., April 12, 2006; 26(15): 3918 - 3922.
[Abstract] [Full Text] [PDF]


Home page
Behav Cogn Neurosci RevHome page
E. Congdon and T. Canli
The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches.
Behav Cogn Neurosci Rev, December 1, 2005; 4(4): 262 - 281.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.